Aura Biosciences (AURA) Other Operating Expenses (2021 - 2022)
Aura Biosciences (AURA) reported Other Operating Expenses of -$5000.0 for Q1 2022, up 99.99% quarter-over-quarter from -$35.2 million in Q4 2021.
Aura Biosciences (AURA) Other Operating Expenses (2021 - 2022) Analysis & Trends
Aura Biosciences has reported Other Operating Expenses for 2 years, with the latest figure at -$5000.0 in Q1 2022.
- For the quarter ending Q1 2022, Other Operating Expenses changed N/A year-over-year to -$5000.0; the trailing twelve-month figure through Dec 2022 stood at -$5000.0 (up 99.99% YoY), and the FY2023 full-year result was $208000.0, up 165.41% from the prior year.
- Other Operating Expenses for Q1 2022 stood at -$5000.0, up from -$35.2 million in the prior quarter.
- The five-year high for Other Operating Expenses was -$5000.0 in Q1 2022, with the low at -$35.2 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Aura Biosciences | 412.10 Mn | 327.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -5,000.00 |
| Dec 31, 2021 | -35.15 Mn |